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ABSTRACT
The optional Escherichia coli restriction tRNase
PrrC represents a family of potential antiviral
devices widespread among bacteria. PrrC com-
prises a functional C-domain of unknown structure
and regulatory ABC/ATPase-like N-domain. The
possible involvement of a C-domain sequence in
tRNA
Lys recognition was investigated using a
matching end-protected 11-meric peptide. This
mimic, termed here LARP (Lys-anticodon recogniz-
ing peptide) UV-cross-linked tRNA
Lys anticodon
stem-loop (ASL) analogs and inhibited their PrrC-
catalyzed cleavage. Trimming LARP or introducing
in it inactivating PrrC missense mutations impaired
these activities. LARP appeared to mimic its match-
ing protein sequence in ability to dimerize in parallel,
as inferred from the following results. First, tether-
ing Cys to the amino- or carboxy-end of LARP
dramatically enhanced the ASL-cross-linking and
PrrC-inhibiting activities under suitable redox con-
ditions. Second, Cys-substitutions in a C-domain
region containing the sequence corresponding to
LARP elicited specific intersubunit cross-links. The
parallel dimerization of PrrC’s C-domains and
expected head-to-tail dimerization of its N-domains
further suggest that the NTPase and tRNA
Lys-
binding sites of PrrC arise during distinct assembly
stages of its dimer of dimers form.
INTRODUCTION
PrrC, the optional Escherichia coli anticodon nuclease
(ACNase) (1,2) represents potential antiviral devices
widespread among bacteria (3). PrrC’s activity is silenced
by the genetically linked type Ic DNA restriction
endonuclease EcoprrI (4–7) and is unleashed by Stp, the
phage T4-encoded peptide inhibitor of EcoprrI (8). The
activation of PrrC causes speciﬁc cleavage of tRNA
Lys
50 to the wobble base (2) and, consequently, could block
T4-late translation and contain the infection (9). However,
the T4-coded RNA healing and sealing enzymes
30-phosphatase/50-polynucleotide kinase (Pnk) and RNA
ligase 1 (Rnl1) (10) normally restore the intact form of
tRNA
Lys (1,2), exercising perhaps their intended functions
(11,12). Known PrrC homologs are invariably linked to
EcoprrI homologs and, hence, could also act as secondary
defenses mobilized when an associated DNA restriction
endonuclease is compromised (3,8,13).
When PrrC is expressed by itself it exhibits overt (core)
ACNase activity (14) that puriﬁes with a homo-oligomeric
PrrC form, possibly a dimer of dimers (3). PrrC’s
N-proximal  265 amino acids are thought to constitute
an NTPase domain that mediates the activation of the
latent ACNase (3,13) (Figure 10A). This region contains
ABC ATPase-like motifs (15), albeit, suﬃciently diﬀerent
from the typical to justify classifying PrrC’s N-domain
as a distinct subtype. The divergent sequence of PrrC’s
N-domain could account for the unusual nucleotide
requirements of the ACNase activation reaction and
PrrC’s idiosyncratic nucleotide binding attributes.
Namely, the activation depends on the cooperation of
GTP and dTTP and is inhibited by ATP. Moreover, dTTP
exhibits higher aﬃnity for PrrC than GTP or ATP
(mM versus mM-range); and dTTP but not GTP or ATP
stabilizes PrrC’s core ACNase activity. PrrC diﬀers from
the typically dimeric ABC ATPases (16) also in its
apparent dimer of dimers structure (3). The remaining
 130 amino acid region of PrrC harbors residues
implicated in tRNA
Lys recognition (17–19) and cleavage
(3) and does not resemble a known protein structure.
The main cues PrrC recognizes in tRNA
Lys map to
the anticodon stem-loop (ASL). They comprise the
anticodon sequence, base modiﬁcations and base-pairing
interactions (17–20).
Peptide mimicry and Cys-mediated intersubunit
cross-linking data reported here suggest that the
tRNA
Lys-binding motif of PrrC is shared by C-domain
portions interfacing in parallel. The proposed parallel
dimerization of the C-domains can be reconciled with the
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by further suggesting that the regulatory and functional
sites of PrrC arise at distinct assembly stages of its dimer
of dimers form.
MATERIALS AND METHODS
Materials
Puriﬁed E. coli tRNA
Lys labeled with
32P at the 33p34
junction (13,21) and synthetic tRNA
Lys ASL analogs
(22,23) were prepared as previously described. The
analogs included ASL-3 that matches mammalian
tRNA
Lys3 in RNA sequence and base modiﬁcations but
contains an extra 30-dT that facilitated its synthesis; and
ASL-C that has the same RNA sequence but base
modiﬁcations of E. coli tRNA
Lys (Figure 1); both were
[50-
32P] labeled as described (19). The synthetic end-
protected peptides used (Figure 2) were purchased from
Genscript Corporation and were over 80% pure.
Diazenedicarboxylic acid (diamide) was purchased from
Sigma.
PrrC mutagenesis
The PrrC forms used contained a C-terminal His6 tag and,
except where indicated, also the leaky D222E mutation
that allows high level expression of the protein (3). The
triple mutant D222E/C268A/C385A termed PrrC
 , its Cys
replacement derivatives and the H356A/F292S double
mutant were generated by Quick Change (24). Other PrrC
mutants have been described (3,17).
PrrC-expression plasmids and bacterial hosts
The PrrC proteins were expressed under the control of the
T7-Lac promoter and Shine–Dalgarno sequence of
plasmid pRRC11 (17) in E. coli Rosetta (DE3)pLysS
(Novagen, UK) encoding T7 RNA polymerase, T7
lyzozyme (25) and rare tRNAs from plasmid pRARE.
The cells were grown in LB medium at 378C to a density of
 6.10
8 cells/ml. They were shifted then to 308C and PrrC’s
expression induced by adding 1mM IPTG. After further
incubation for 2h, the cells were harvested and the
PrrC proteins puriﬁed by immobilized metal aﬃnity
chromatography as described (3).
Diamide treatment of cellsexpressing PrrC to-Cys mutants
Escherichia coli cells induced to express the indicated
PrrC forms were harvested by high-speed centrifugation,
re-suspended in 0.01vol of 10mM diamide in water and
incubated at 108C for the indicated time. The cells
were then lyzed by heating them for 1min at 1008Ci n
SDS–PAGE sample buﬀer, their proteins were separated
by SDS–PAGE and PrrC monitored by immunoblotting
using puriﬁed polyclonal anti-PrrC antibodies (17).
ACNaseisolation and assays
The standard core ACNase form used in the in vitro assays
was a His6-tagged derivative of the leaky PrrC mutant
D222E. It was puriﬁed by TALON (Clontech) aﬃnity
chromatography followed by Superdex-200 gel ﬁltration
(3). The standard ACNase reaction mixture (10ml)
contained 1 fmol of the
32P-labeled E. coli tRNA
Lys or
the indicated [50-
32P] labeled ASL, both at 3000Ci/mmol;
2mM dTTP, 4mM Na-HEPES buﬀer, pH 7.5; 0.5mM
MgCl2, 15mM NaCl, 5% glycerol and 0.5M
trimethylamine-N-oxide (TMAO). The reaction was
Figure 1. ASL analogs of tRNA
Lys and their modiﬁed bases. (A and B) Secondary structure presentations and indicated tRNA positions of
ASL-3 and ASL-C, respectively. (C) Notations and structures of modiﬁed ASL bases. U9 (mcm
5s
2U), A9 (ms
2t
6A) appear in human tRNA
Lys3,
U8 (mnm
5s
2U) and A7 (t
6A) in corresponding positions of E. coli tRNA
Lys and  appears in both.
Figure 2. Sequences of LARP and LARP derivatives used in this work.
All the peptides used were protected at their N- and C-ends by
respective acetyl and amide groups.
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and terminated at the indicated time by adding 1.5 vol of
10M urea, 0.01% bromphenol blue and 0.01% xylene
cyanol. The products were separated by polyacrylamide–
urea gel electrophoresis and quantiﬁed by densitometry or
counting.
Peptide-RNA UV-cross-linking
Peptide-RNA UV-cross-linking was performed in
mixtures (10ml) containing  0.1pmol of [50-
32P] labeled
ASL-3, 0.1–2.0nmol of Lys-anticodon recognizing peptide
(LARP) or indicated LARP derivative, 5mM Na-HEPES
buﬀer, pH 7.5; 1mM MgCl2, 30mM NaCl, 0.5–1.0M
TMAO and 10% glycerol. The mixture was placed in a
35-mm polystyrene culture dish and irradiated for 5min at
48C over a TFX-20M transilluminator providing radia-
tion spectrum with a peak at 312nm. Aliquots were mixed
with 1.5 vol of 10M urea containing 0.01% each of xylene
cyanol and bromphenol blue and separated by denaturing
gel electrophoresis.
PrrC-RNA UV-cross-linking
ThePrrC mutant proteins H356A and H356A/F292S were
cross-linked to ASL-3 in 12ml ACNase reaction mixtures
essentially as described above but containing 0.3 pmol of
ASL-3 and  1mg of the indicated PrrC allele puriﬁed by
TALON cobalt aﬃnity chromatography. The mixture was
irradiated for 5min at 48C as described for the LARP-
ASL-3 cross-linking. An equal volume of 2  SDS–PAGE
gel sample buﬀer devoid of reducing agent was added and
the products separated by 10% SDS–PAGE. The proteins
were transferred then to a nitrocellulose membrane, PrrC
monitored by immunoblotting using anti-PrrC antibodies
(17) and the PrrC/ASL-3 cross-linking product detected
by autoradiography.
Glutaraldehyde(GA)-mediatedprotein–proteincross-linking
The indicated PrrC forms were subjected to GA-mediated
protein–protein cross-linking as previously described and
the products monitored by immunoblotting (3).
RESULTS AND DISCUSSION
The synthetic 11-mer LARP matching PrrC residues
284–294inhibits ACNase activity
Mutations that alter ACNase cleavage speciﬁcity have
implicated PrrC’s Asp
287 in tRNA
Lys recognition (17–19).
Asp
287 maps to a consensus sequence shared by a subset of
the known PrrC homologs. This sequence comprises a
predicted coil region (284–92) and the essential aromatic
residues Phe
292 and Tyr
294 (Figure 3) (3,17). Its possible
role in tRNA
Lys recognition was investigated using an
end-protected mimic (Ac-KYGDSNKSFSY-NH2).
This mimic was termed LARP to indicate its anticipated
function. LARP inhibited PrrC’s ACNase activity in a
dose-dependent manner when assayed with E. coli
tRNA
Lys (Figure 4A and B) or ASL analogs
(Figure 4C–E). An IC50 value of  10
–4M was obtained
in all cases. The inhibition decreased with increasing
substrate level within the range examined (Figure 4F
and G). These results hinted that LARP acted by
occluding the RNA substrate and/or competing with the
substrate over the protein.
      279    287                                        330aa(Eco)   
        |      |                                          |          
SSpro   EEEECCCCCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHC   
Jpred   EEECCCCCCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHCC
                        
Eco     ALTEKYGDSNKSFSYHLHLKQTIEQAIADNNVERYHFTLLRNLYEKTASFL 
Yfr     EIEDKKGDSNKSFSYHLYIKRLIEQAIEKNEVQRYHFTLLRNLYEKSANFL 
Nme     DILEKQGDSNKSFSYHLHLKGVIEKAIENQQVERFHFMLLRNLYEKTANFL 
Hin     DLEEKQGGSNKSFSYHLFLRNLLE-EVESKDIQKYHFMLLRNLYEKTANFL 
Apl     ELHTKKGDSNTSFNYHIYLKHTLENAISNNAIEKYHFTLLRNLYEKTASFL 
Lin     SYELANQSTDSPFSYHLHLKAELEKAIETGQLHKYHFNFLRNILEKTSTFV 
Plu     TYQLAIQPNDSPFSYHLYLKSELEKAIENGQLSKYHFNFLRNILEKTSTFL 
Rhp     TFSLSPQPNDSPFSYHLYLLRELQAASENGEIKKYHFNFIRNILEKSSTFL 
Smu     KYLLNSQDNDAPFAYHLMLVDELKKAIAEDRVEKYHFNLLRNLLEKTATFL 
Bli     GWTLARQSKDSPFSYHLGIIKDIQEAISANAIERSHFNQFRALLEKTANFL 
                    : :*:     :        :   **   * : *::: *   
Figure 3. Multiple sequence alignment of a region containing a residue implicated in tRNA
Lys recognition. Escherichia coli PrrC (indicated by Eco)
residues 279–330 were aligned using ClustalW (31) with corresponding portions of representative homologs detected by BLAST (32). Secondary
structure predictions according to SSpro (33) and Jpred (34) are indicated above the alignment. The region corresponding to LARP in a subset of the
homologs is shaded. The arrows indicate residues whose replacement by Cys triggered intersubunit cross-links (Figure 9). The PrrC homologs
indicated by the three-letter abbreviations are encoded by the following bacteria and indicated by the respective accession numbers: Yfr—Yersinia
frederiksenii ATCC 33641, ZP_00829622.1; Nme—Neisseria meningitidis MC58, Hin—Haemophilus inﬂuenzae R2846, ZP_00154666.1;
Lin—Leptospira interrogans serovar Copenhageni str. (Lin.), NC_005823.1; YP_000904.1; Photorhabdus luminescens subsp. laumondii TTO1 (Plu),
NP_931496.1; RhpRhodopseudomonas palustris HaA2, NZ_AALQ01000003.1; Smu—Streptococcus mutans, NC_004350.1; Bli—Brevibacterium linens
BL2 H, NZ_AAGP01000001.1. Identical residues shared by all homologs are marked in red, conserved residues in green.
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The possible interaction of LARP with the ACNase
substrate was tested by attempting to UV-cross-link the
peptide to ASL-3. The cross-linking was performed at
312nm where the tRNA
Lys wobble base is highly
photoreactive (26). Several cross-linking products were
obtained in amounts proportional to the dose of LARP
(Figure 5A and B). The most abundant (designated a) was
retarded in gel electrophoresis relative to ASL-3 by the
equivalent of  4nt, possibly due to a single LARP
adduct. Slower migrating products designated b-d could
contain additional LARP moieties, judged from their
incremental retardations and dependence on LARP.
Presumably, they arose through peptide–peptide cross-
links since data shown below suggested that LARP could
also self-interact (Figures 8 and 9). The non-irradiated
mixture yielded weaker bands over a continuous distri-
bution trailing behind ASL-3 (lane 2), probably non-
covalent complexes that partially dissociated during the
fractionation.
Figure 4. LARP inhibits ACNase activity. (A) Eﬀect of LARP on the PrrC-catalyzed cleavage of E. coli tRNA
Lys. The ACNase assay was performed
in the presence of the indicated LARP levels and aliquots analyzed at the indicated time points. (B) Time course of the reactions of panel A.
(C and D) Eﬀect of LARP on the respective PrrC-catalyzed cleavages of ASL-3 or ASL-C. Only 15-min time points are shown. (E) ASL-3 or ASL-C
cleavage by PrrC versus LARP’s level. (F and G) Eﬀect of LARP on ACNase activity at diﬀerent ASL-3 levels. tRNA
Lys fr. 1–33, ASL-3 fr. 1–7 and
ASL-C fr. 1–7, respective labeled ACNase cleavage products of tRNA
Lys, ASL-3 and ASL-C.
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ACNase-inhibiting activities
LARP was mutated to evaluate the importance of its
sequence to the ASL-cross-linking and ACNase-inhibiting
activities. Trimmed derivatives lacking Lys
1 (1) or Tyr
11
(11) formed UV-cross-links to ASL-3 7- or 3-fold less
eﬃciently than LARP, respectively (Figure 6A). The
conjugates obtained with the trimmed mutants (desig-
nated a0,a
 , b0 and b
 ) were less retarded than those of
LARP, possibly due to their lower mass. 1 and 11 also
hardly inhibited ACNase (Figure 6B).
LARP’s sequence was also changed by PrrC missense
mutations that confer an ACNase null phenotype. These
mutations: F292S (17), Y294S or Y294F (3) were
respectively termed F9S, Y11S and Y11F in the peptide
context. They were introduced in a LARP derivative
containing an extra N-terminal Cys (CLARP, described in
more detail later). CLARP was far more eﬃcient than
LARP both in cross-linking ASL-3 and inhibiting
ACNase (Figure 8) and using it as the reference peptide
facilitated the detection of residual mutant activities.
F9S and Y11S impaired the two activities in a
correlated manner. The milder Y11S mutation reduced
the yield of the primary UV-cross-linking conjugate with
ASL-3 nearly 2-fold (Figure 7A, lane 3 versus 4) and
partially impaired the inhibition of ACNase (Figure 7B,
lane 3 versus 4). It is noteworthy that this mutation also
prevented the formation of a stable secondary conjugate,
as inferred from the absence of the expected band b and
appearance instead of a smear trailing behind band a. The
more drastic mutation F9S reduced the cross-linking to
ASL-3 8-fold (Figure 7A, compare lanes 8 and 9)
and severely impaired ACNase inhibition (Figure 7B,
compare lanes 8 and 9). The corresponding PrrC mutation
F292S could also abrogate the UV-cross-linking of PrrC
to ASL-3. This was inferred from the observation that the
active site PrrC mutant H356A, which lacks ACNase
activity (3) but eﬃciently binds tRNA
Lys (data not
shown), formed UV-cross-links to ASL-3 30-fold more
eﬃciently than F292S/H356A (Figure 7C).
The Y11F mutation conferred a diﬀerent phenotype.
It nearly abolished the ACNase-inhibiting potential of
CLARP (Figure 7B, compare lanes 2, 3 and 5) yet doubled
the yield of the primary UV-cross-linking conjugate
obtained with ASL-3 (Figure 7A, compare lanes 3 and
5). In part this increase could be ascribed to the failure of
Y11F to form stable higher conjugates, as with Y11S.
Nonetheless, the overall cross-linking yield obtained
with Y11F suggested that this mutant bound ASL-3at
least as eﬃciently as CLARP. The discrepant behavior
Figure 6. Eﬀect of trimming LARP on its ASL-3 cross-linking and
ACNase-inhibiting activities. (A) The UV-cross-linking of the indicated
peptides (employed each at 200mM) to ASL-3 was performed
essentially as in Figure 3A. (B) Eﬀect of the indicated peptides on
the PrrC-catalyzed cleavage of ASL-3. The ACNase assay was
performed essentially as in Figure 2C. a and b indicate respective
cross-linking products assumed to contain one or two LARP moieties
per ASL-3; a0 and b0 indicate corresponding cross-linking conjugates of
1, a
  and b
  indicate cross-linking conjugates of 11.
Figure 5. LARP UV-cross-links ASL-3. (A) LARP was cross-linked to
ASL-3 by irradiating their mixture at 312nm (UV) as detailed in the
Methods section. Lanes: 1, ASL-3 irradiated alone; 2, Non-irradiated
mixture of ASL-3 and LARP (330mM); 3–8, Irradiated mixtures of
ASL-3 with the respective levels of LARP: 8.25, 16.5, 33, 82.5, 165 or
330mM. XC, dye marker corresponding in position to a 22nt
oligoribonucleotide; a–d indicate cross-linking products assumed to
contain one, two, three or four LARP moieties per ASL-3, respectively.
(B) Relative levels of the primary (a), secondary (b) and tertiary
(c) conjugates versus that of LARP. The amount of primary conjugate
formed at the highest LARP level is assigned a value of 1.0.
4708 Nucleic Acids Research, 2007, Vol. 35, No. 14of Y11F hinted that the ACNase-inhibiting forms of
LARP exerted their eﬀect not only by occluding the
RNA substrate but also by forming a binary complex
with PrrC. Since LARP was employed in excess over
PrrC and ASL-3, it could exert these two ACNase-
inhibiting modes independently. The possibility that
LARP interacted with PrrC directly was reinforced by
data shown below suggesting that both LARP and its
matching PrrC sequence can self-interact (Figures 8
and 9). The failure of the Y11S and Y11F mutants to
form stable conjugates containing additional
peptide moieties could not be ascribed to a critical
role of Tyr
11 in peptide–peptide UV-cross-linking since
deleting this residue did not elicit such an eﬀect
(Figure 6A, lane 5).
Extending LARP withCys augments its activities under
suitable redox conditions
LARP derivatives extended at the N- or C-end with Cys
(CLARP and LARPC, respectively) were intended for
further modiﬁcation with Fe-EDTA that rendered them
artiﬁcial nucleases (M. Amitsur, D. Klaiman and
G. Kaufmann; unpublished data). Unexpectedly,
CLARP and, to a lesser extent, LARPC were far more
potent than LARP in UV-cross-linking ASL-3 and
inhibiting ACNase. Thus, when CLARP, LARPC or
LARP were UV-cross-linked to ASL-3at 1mM DTT and
identical peptide levels, similar product patterns were
obtained. However, the product yields with CLARP or
LARPC were about an order of magnitude higher than
with LARP (Figure 8A). Employing the Cys-containing
peptides at a level 10-fold lower than that of LARP
resulted in comparable yields (Figure 8B). CLARP and
LARPC UV-cross-linked ASL-3 more eﬃciently than
LARP also without DTT, LARPC yielding under these
conditions a relatively high proportion of the secondary
conjugate (Figure 8C). However, the cross-linking eﬃ-
ciency of CLARP and LARPC to ASL-3 was relatively
weak at 10mM DTT (Figure 8D). CLARP and LARPC
inhibited ACNase more strongly than LARP at 1mM
DTT (Figure 8E) but were less eﬀective than LARP at
10mM DTT (Figure 8F).
Thus, tethering Cys to one or the other end of LARP
enhanced the ACNase-inhibiting and ASL-3 cross-linking
activities of the peptide although not under highly
reducing conditions. Moreover, LARPC yielded under
oxidizing conditions higher proportions of conjugates
likely to contain two peptide moieties per ASL-3. These
facts may be accounted for by the stabilization of a
common functional form of LARP both by a C-terminal
or N-terminal S-S bond, a requirement satisﬁed by a
parallel but not a head-to-tail LARP dimer. An alternative
explanation is that mere dimerization of LARP by a
disulﬁde bond at either end increased the probability of
non-speciﬁc electrostatic, hydrogen bonding and stacking
interactions between the peptide and the RNA.
The tethered Cys residue enhanced the UV-cross-
linking eﬃciency of LARP to ASL-3 optimally at
intermediate redox conditions (1mM) rather than oxidiz-
ing conditions. This outcome suggested that
reversible formation of the disulﬁde link facilitated the
Figure 7. ASL-3 cross-linking and ACNase-inhibiting activities of missense mutants of CLARP. (A) The UV-cross-linking of CLARP and its
indicated missense mutants to ASL-3 was performed essentially as in Figure 3A except that the peptide level was only 20mM. (B) The eﬀect of
CLARP and its indicated missense mutants on PrrC-catalyzed cleavage of ASL-3 was determined essentially as in Figure 2C except that the peptide
level was 20mM. (C) The F292S mutation of PrrC inhibits the UV-cross-linking of the protein to ASL-3. ASL-3 was UV-cross-linked to the indicated
alleles of PrrC. The products were separated by SDS–PAGE, transferred to a nitrocellulose membrane and detected by immunoblotting and
autoradiography as detailed in the Methods section. a and b indicate respective cross-linking products assumed to contain one or two LARP moieties
per ASL-3. ASL-3 fr. 1–7; labeled ACNase cleavage product of ASL-3; PrrC/ASL-3 and PrrC2/ASL-3, respective UV-cross-linking products of
ASL-3 with a PrrC monomer or PrrC dimer. X-linking, cross-linking.
Nucleic Acids Research, 2007, Vol. 35, No. 14 4709ﬁxation of original LARP–LARP and LARP–RNA
contacts by UV-cross-linking. In other words, a stable
S-S bond could impede the UV-cross-linking by
constraining the dimer.
Placing Cys ator nearthe PrrC region matching LARP
triggers intersubunit cross-links
The suspicion that LARP exerted its ASL-3 cross-linking
and ACNase inhibiting activities as a parallel dimer
prompted us to examine if the matching PrrC sequence
dimerizes similarly. To this end, a Cys residue was
introduced in this sequence instead of Ser
288, Ser
291 or
Ser
293. We expected that the mutant Cys residues will
self-interact and form intersubunit disulﬁde cross-links
if the region containing them dimerizes in parallel.
Each of the three mutations was placed over the D222E/
C268A/C385A background termed PrrC
 . This facilitated
the isolation of the mutant proteins (3,17) and precluded
Figure 8. Cys extensions enhance LARP activities under suitable redox conditions. (A) Terminal Cys extensions enhance the UV-cross-linking of
LARP to ASL-3. The indicated peptides employed each at 0.2mM were UV-cross-linked to ASL-3 in the presence of 1mM DTT. (B–D) Eﬀect of the
DTT level on the cross-linking eﬃciencies of LARP, CLARP and LARPC on their ability to form UV-cross-links to ASL-3. LARP, CLARP and
LARPC employed at the indicated concentrations were UV-cross-linked to ASL-3at 1mM DTT (panel B), without DTT (panel C) or at 10mM
DTT (panel D). (E) Eﬀect of LARP, CLARP and LARPC on ACNase activity at 1mM DTT. The incubation times were 2 (lanes 2, 5, 8, 11, 14
and 17), 5 (lanes 3, 6, 9, 12, 15 and 18) and 10min (lanes 4, 7, 10, 13, 16 and 19). (F) Eﬀect of 10mM DTT on the ACNase-inhibiting potential of
LARP, CLARP or LARPC. The incubation times were 2 (lanes 2, 5, 8, 11, 14, 17 and 20), 5 (lanes 3, 6, 9, 12, 15, 18 and 21) and 10min (lanes 4, 7,
10, 13, 16, 19 and 22). a–c indicate respective cross-linking products assumed to contain one, two or three LARP moieties per ASL-3; a0-c0,
corresponding products of CLARP and LARPC. ASL-3 fr. 1–7, labeled ACNase cleavage product of ASL-3.
4710 Nucleic Acids Research, 2007, Vol. 35, No. 14the formation of non-speciﬁc S-S cross-links due to
the wild-type Cys residues. The PrrC
  control
and to-Cys derivatives exhibited comparable in vivo
ACNase activities and protein levels (data not shown).
However, only PrrC
  and S288C/PrrC
  retained ACNase
activity in vitro (Figure 9A).
To induce the formation of S-S cross-links the cells
expressing the to-Cys mutants or the PrrC
  control were
Figure 9. Cys substitutions within or near the PrrC region corresponding to LARP trigger inter-subunit cross-links. (A) In vitro ACNase activity of
PrrC* and the indicated to-Cys derivatives of PrrC*. These PrrC forms were isolated by aﬃnity chromatography and assayed for ACNase activity as
detailed in the Methods section. (B) Escherichia coli cells expressing the indicated PrrC forms were suspended in 10mM diamide and incubated at
108C for the indicated time. The cells were lyzed, their proteins separated in SDS–PAGE without a reducing agent and PrrC visualized by
immunoblotting. (C) The indicated PrrC forms were puriﬁed by TALON immobilized-metal aﬃnity-chromatography and further fractionated by
SDS–PAGE, as such (lanes 1, 4, 7 and 10), after treatment with 1mM DTT (lanes 2, 5, 8 and 11) or further treatment with 2mM diamide (lanes 3, 6,
9 and 12) and then monitored by immunoblotting. (D) The indicated PrrC forms were treated as in panel C and monitored by protein staining.
(E) The indicated PrrC forms were subjected to GA-mediated protein–protein cross-linking. (F) The indicated PrrC mutant forms were analyzed as in
panel B: L298C (lanes 1–3), Q300C (lanes 4–6), I302C (lanes 7–9), I306C (lanes 10–12), PrrC
  (lanes 13–15), PrrC-D222E (lanes 16–18). The bands
indicated as Xa and Xb are in respective order the common form of band X generated by the majority of the to-Cys mutants and the faster migrating
form generated only by Q300. ASL-3 fr. 1–7, labeled ACNase cleavage product of ASL-3 containing residues 1–7; kDa, protein size markers; 2mers,
3mers and 4mers, indicate cross-linking forms thought to contain 2, 3 or 4 PrrC subunits, respectively; M, PrrC monomer; X, the major S-S cross-
linking product.
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separated then by SDS–PAGE under non-reducing con-
ditions and PrrC visualized by immunoblotting.
As shown, the three mutants, but not PrrC
  yielded
products that migrated in SDS–PAGE slower than the
 47.5-kDa PrrC monomer (Figure 9B). These products
included a major form designated X that migrated below
the 175-kDa size marker as well as several less pronounced
and faster migrating forms. These various products
appeared also without diamide, perhaps due to partial
in vitro oxidation. However, their amounts increased
considerably with diamide, consistent with their formation
by disulﬁde cross-linking.
To determine if any of the diamide-dependent products
arose by intra-PrrC cross-links, the four PrrC forms were
isolated by immobilized metal aﬃnity chromatography in
the absence of a reducing agent. Subsequently they were
fractionated by SDS–PAGE as such, after prior treatment
with 1mM DTT or also with 2mM diamide. Western
analysis revealed that the puriﬁed Ser!Cys mutants,
but not PrrC
 , yielded a single product with mobility
similar to that of band X of the diamide treated cells
(compare Figure 9C, lanes 1, 4, 7 and 10 to Figure 9B
lanes 4, 8, 12 and 16). Moreover, this band was abolished
by DTT (Figure 9C. lanes 2, 5, 8 and 11) and restored by
excess diamide (lanes 3, 6, 9 and 12), indicating
it depended on disulﬁde cross-linking. Corresponding
protein staining (Figure 9D) ascertained that the various
PrrC forms were not contaminated by signiﬁcant amounts
of other proteins and, consequently, that band X was
unlikely to contain proteins other than PrrC. The failure
of a considerable fraction of the to-Cys mutant proteins to
generate band X could be attributed to its misfolding since
PrrC is thermally unstable. Alternatively, this fraction
could represent a functionally relevant conformation
incompatible with the S-S cross-linking; e.g. due to a
substrate or inhibitor bound to the tRNA
Lys site.
Band X migrated in SDS–PAGE less than expected of a
cross-linked PrrC dimer of  95kDa. This fact could
be attributed to its particular shape or irreversible
entanglement of two such dimers within the PrrC
tetramer. To distinguish between these possibilities, we
subjected PrrC
  and S293C/PrrC
  to GA-mediated
protein–protein cross-linking. PrrC
  yielded the familiar
pattern (3) where the monomer is gradually converted into
apparent GA-cross-linked tetramer forms via dimeric
and less pronounced trimeric intermediates (Figure 9E,
lanes 1–4). The monomeric fraction of the mutant
behaved similarly (lanes 5–8). Band X, which coincided
with the most retarded GA-cross-linked dimers, was also
gradually converted into higher forms superimposed over
those generated by the fraction that failed to form the S-S
cross-links. These data suggested that band X was a dimer
that was retarded due to its particular shape.
We analyzed in a similar fashion PrrC
  derivatives
containing Cys in the predicted a-helix found immediately
downstream to the LARP-like region (Figure 3).
It replaced L298, I302 or I306 of the a-helix hydrophobic
face or the hydrophilic Q300. These mutants also
yielded the S-S cross-linked form designated X, L298C
yielding the highest proportion (Figure 9F, lanes 1–3),
possibly due to closer contact of the dimerizing a-helices
at position 298. Q300C yielded a variant (designated Xb)
that migrated slightly faster than the form X
generated by the other mutants designated here Xa
(Figure 9F, compare lanes 3 and 4, 6 and 7). The slight
mobility diﬀerence may be attributed to the presence of
Cys
300 at the hydrophilic and, hence, outward-pointing
face of the dimerizing a-helix. Consequently, an S-S cross-
link mediated by it could constrain the dimer into a
more compact, faster migrating form. The PrrC mutant
D222E containing the wild-type residues Cys
268
and Cys
385 failed to generate band X (Figure 9F, lanes
16–18). This result underscored the speciﬁcity of the
intersubunit cross-links triggered by the mutant Cys
residues placed in the 288–306 range.
Peptide mimicry oftRNA
Lys recognition byPrrC
LARP formed UV-cross-links to ASL analogs of
tRNA
Lys and inhibited their PrrC-catalyzed cleavage
Figure 10. PrrC’s functional organization and possible quaternary topology. (A) Functional organization of PrrC. The crimson bar represents the
N-proximal NTPase domain, the green bar the C-proximal ACNase domain. The ABC ATPase-like motifs indicated below the bar are, from left to
right, the Walker A (P-loop), ABC signature, Walker B/D loop and switch region motifs (15). The PrrC-box motif indicated above the bar is unique
to the PrrC proteins. The D222E mutation in this domain attenuates ACNase activity and facilitates the overproduction and isolation of PrrC (3).
In the C-proximal ACNase domain are indicated the sequence matching LARP thought to partake in tRNA
Lys recognition, the conserved putative
catalytic residues Arg
320, Glu
324 and His
356 (3), the seven to-Cys mutations in the 288–306 range and the wild-type Cys residues at the edges of the
domain that were replaced by Ala in PrrC
 .( B) Proposed quaternary topology of PrrC. According to this model, the nucleotide binding pockets arise
by head-to-tail interaction of the regulatory N-domains (crimson rectangles), as in ABC/ATPases (15). The tRNA
Lys-sites are formed at parallel
dimer–dimer interfaces between the ACNase C-domains (green squares). The upper dimer (darker forms) obscures part of the lower dimer
(paler forms). P-loop, Walker A motif, ABC, ABC signature motif.
4712 Nucleic Acids Research, 2007, Vol. 35, No. 14(Figures 4 and 5). Moreover, the two activities were
impaired by trimming LARP (Figure 6) or placing in it
missense mutations that confer a null ACNase phenotype
in the PrrC context (Figure 7). Importantly, the CLARP
mutation F9S and the corresponding inactivating PrrC
mutation F292S severely inhibited the respective UV-
cross-linking of ASL-3 to the peptide (Figure 7A) or
protein (Figure 7C). These results could be taken to
indicate that LARP mimics its matching PrrC sequence
in tRNA
Lys recognition. However, even in that case
LARP would probably represent only part of PrrC’s
tRNA
Lys-binding motif since the level at which it
eﬀectively inhibited ACNase (Figure 4) far exceeds the
Km of eﬃcient ACNase substrates (19). Moreover, known
RNA-binding motifs including that of colicin E5-ACNase
are several fold longer than LARP (28,29).
The tRNA
Lyssite of PrrC mayarise between C-domains
interfacing inparallel
The functional relevance of LARP to its matching PrrC
region was suggested also by the apparent ability of both
to dimerize in parallel. We deduced that LARP acted as a
parallel dimer in forming UV-cross-links to ASL-3 and
inhibiting ACNase from the ability of a single Cys residue
tethered to either the N- or C-end of LARP to
dramatically enhance these activities and abolition of
these enhancements under highly reducing conditions
(Figure 6). These coincidences could be accounted for by
the stabilization of a common functional dimeric structure
of LARP by a disulﬁde bond formed at one or the other
end of its protomers, a requirement met by a parallel but
not anti-parallel dimer. Alternatively, the similar eﬀects of
the N- and C-proximal Cys extensions reﬂected the
increased probability of non-speciﬁc peptide–RNA inter-
actions caused by mere dimerization of the peptide,
whether caused by the N- or C-terminal S-S bond.
However, we favor the ﬁrst explanation in view of the
intersubunit S-S cross-links triggered by all seven
Cys substitutions placed along the C-proximal PrrC
288–306aa region overlapping the sequence matching
LARP (Figure 9). Such an outcome is consistent with
parallel dimerization of the mutated region and lends
support to the assumption that LARP could also dimerize
in this orientation. The PrrC region that dimerizes in
parallel could be conﬁned to a portion of the ACNase
domain since the regulatory N-domain is expected
to dimerize in a head-to-tail fashion, like typical
ABC/ATPases where the nucleotide binding pocket
arises by the interaction of the Walker A motif of one
subunit with the ABC signature motif of the second (15).
Moreover, the wild-type Cys
268 and 385 at the edges of the
C-domain (Figure 10A) did not trigger intersubunit cross-
links (Figure 9F). The relation of the PrrC region that
dimerizes in parallel to the tRNA
Lys-binding motif may be
revealed by accurately mapping and functionally char-
acterizing it.
Finally, as illustrated in Figure 10B, the opposite
orientations in which PrrC’s N- and C-domains dimerize
dictate a phosphofructokinase-like topology (30) where
the NTPase and tRNA
Lys sites arise at distinct assembly
stages of the PrrC dimer of dimers (3).
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